Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2024 -10.12M
June 30, 2024 -8.963M
March 31, 2024 -13.53M
December 31, 2023 -10.34M
September 30, 2023 -15.42M
June 30, 2023 -6.347M
March 31, 2023 -17.96M
December 31, 2022 -10.41M
September 30, 2022 -17.38M
June 30, 2022 -18.03M
March 31, 2022 -16.50M
December 31, 2021 -12.14M
September 30, 2021 -13.96M
June 30, 2021 -12.48M
March 31, 2021 -10.66M
December 31, 2020 -9.909M
September 30, 2020 -11.26M
June 30, 2020 -10.68M
March 31, 2020 -14.95M
December 31, 2019 -14.04M
September 30, 2019 -14.17M
June 30, 2019 -15.65M
March 31, 2019 -15.15M
Date Value
December 31, 2018 -15.15M
September 30, 2018 -10.77M
June 30, 2018 -12.32M
March 31, 2018 -12.91M
December 31, 2017 -18.19M
September 30, 2017 -14.08M
June 30, 2017 -15.46M
March 31, 2017 -14.70M
December 31, 2016 -14.55M
September 30, 2016 -12.78M
June 30, 2016 -14.05M
March 31, 2016 -13.43M
December 31, 2015 -12.03M
September 30, 2015 -11.64M
June 30, 2015 -11.00M
March 31, 2015 -10.62M
December 31, 2014 -9.076M
September 30, 2014 -8.849M
June 30, 2014 -9.209M
March 31, 2014 -8.826M
December 31, 2013 -13.28M
September 30, 2013 -4.642M
June 30, 2013 -6.925M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
ABVC BioPharma, Inc. -1.390M
Anika Therapeutics, Inc. -0.311M
Perspective Therapeutics, Inc. -32.44M
MiMedx Group, Inc. -8.683M
Abbott Laboratories 920.00M